Skip to main content
logo
aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.5189
-0.0401 (-7.17%)
At close: Aug 17, 2026, 4:00 PM EDT
0.5200
+0.0011 (0.21%)
After-hours: Aug 17, 2026, 5:41 PM EDT

aTyr Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
51773048364208
Market Cap Growth
-89.91%-74.75%268.02%29.97%-69.40%425.30%
Enterprise Value
5-1251-5-593
Last Close Price
0.560.783.621.412.197.47

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
270.36403.861293.07233.916.12-
PB Ratio
1.121.144.350.910.891.90
P/TBV Ratio
1.051.144.340.910.891.90

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
27.63-1069.23---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.230.180.190.170.160.01
Net Debt / Equity Ratio
-0.95-0.99-0.84-0.92-0.77-0.98
Net Debt / EBITDA Ratio
0.730.870.881.531.183.18
Net Debt / FCF Ratio
0.841.070.852.221.253.20
Asset Turnover
0.000.000.000.000.10-
Quick Ratio
5.085.254.936.135.6218.02
Current Ratio
5.125.305.486.275.8318.89
Return on Equity (ROE)
-98.68%-108.11%-79.88%-62.31%-50.27%-48.04%
Return on Assets (ROA)
-46.58%-51.12%-39.03%-31.72%-27.45%-27.56%
Return on Capital Employed (ROCE)
-109.30%-99.70%-83.00%-52.70%-56.60%-31.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-118.37%-96.59%-21.07%-61.03%-71.36%-16.27%
FCF Yield
-106.72%-80.88%-22.77%-45.34%-68.51%-16.02%
Buyback Yield / Dilution
-16.75%-25.21%-38.53%-88.63%-48.94%-108.30%
SEC Filings: 10-K · 10-Q